Proliferation activity in bladder tumors does not correlate with the pathological grading.

Area of Science:

• Oncology
• Cancer Biology
• Urothelial Carcinomas

Background:

• Bladder cancer is a growing global health concern, particularly in men, with smoking as a primary risk factor.
• Transitional cell carcinoma accounts for over 90% of bladder cancers, posing histopathological assessment challenges related to prognosis.
• Understanding molecular markers is crucial for predicting bladder cancer behavior and invasiveness.

Purpose of the Study:

• To identify common expression patterns of specific markers in bladder tumors.
• To correlate marker expression with tumor grade, invasion depth, and clinical prognosis.
• To investigate the role of cytokeratins, VEGF, CD34, MMPs, and Ki67 in bladder cancer progression.

Main Methods:

• Analysis of 32 confirmed bladder tumors.
• Evaluation of marker expression including cytokeratin 7 (CK7), CK20, vascular endothelial growth factor (VEGF), CD34, matrix metalloproteinases (MMPs) 2, 8, and 9.
• Assessment of Ki67 proliferation index and vascular density.

Main Results:

• CK7 and CK20 showed varied expression across different tumor areas and grades.
• MMP9 exhibited more consistent expression than MMPs 2 and 8.
• Vascular density did not significantly increase in high-grade invasive tumors compared to low-grade tumors.
• High Ki67 proliferation was noted in high-grade superficial tumors, but inversely correlated at advancing tumor edges.

Conclusions:

• Expression patterns of CK7, CK20, and MMPs vary in bladder cancer, offering potential diagnostic insights.
• The complex correlation of Ki67 proliferation with tumor grade and invasiveness warrants further investigation.
• Further research is needed to elucidate signaling pathways driving urothelial tumor invasiveness.